Table 4. Risks for the development of 30% decline in eGFR by monocyte tertiles and renal hyperfiltration (RHF).

Monocyte tertiles	No RHF	RHF
	HR (95% CI)	HR (95% CI)
1st	1.00	2.438 (0.824–7.218)
2nd	0.988 (0.521–1.874)	3.420 (1.188–9.847)
3rd	1.645 (0.922–2.935)	3.822 (1.327–11.006)

Risk are adjusted by age, sex, systolic blood pressure, body mass index, estimated glomerular filtration rate, fasting glucose, hemoglobin, aspartate transaminase, aspartate aminotransferase, alkaline phosphatase, total cholesterol, diabetes, hypertension, coronary artery disease, and malignancy.